Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.37 |
| ▸ | CA1 | P00915 | 3/20 | 0.37 |
| ▸ | CA2 | P00918 | 3/20 | 0.37 |
| ▸ | CA9 | Q16790 | 3/20 | 0.37 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9452614 | 0.83 | CA12 (0.37) | CA12CA1CA2CA9PIK3CD | |
| SCHEMBL3889745 | 0.72 | CA12 (0.37) | CA12CA1CA2CA9PIK3CD | |
| SCHEMBL5392828 | 0.72 | CA12 (0.42) | CA12CA1CA2CA9PIK3CD | |
| SCHEMBL9876483 | 0.70 | CA12 (0.37) | CA12CA1CA2CA9 | |
| SCHEMBL379577 | 0.67 | — | — | |
| SCHEMBL18245272 | 0.65 | CA12 (0.36) | CA12CA1CA2CA9 | |
| SCHEMBL29062254 | 0.63 | ALDH1A1 (0.41) | CA12CA1CA2CA9TRPM8 | |
| SCHEMBL9503075 | 0.63 | FDPS (0.37) | CA12CA1CA2 | |
| SCHEMBL14312089 | 0.63 | TRPM8 (0.48) | CA1TRPM8 | |
| SCHEMBL18244853 | 0.62 | CA12 (0.30) | CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9637515-B2 | Guggulphospholipid methods and compositions | JINA PHARMACEUTICALS, INC. (US) | 2017-05-02 | — | — | US | claimed |
| EP-2088865-B1 | GUGGULPHOSPHOLIPID METHODS AND COMPOSITIONS | JINA PHARMACEUTICALS INC (US) | 2015-10-21 | — | — | EP | claimed |
| US-20100151002-A1 | Guggulphospholipid Methods and Compositions | JINA PHARMACEUTICALS, INC. (US) | 2010-06-17 | — | — | US | claimed |
| US-20250243540-A1 | PROBE RELATED REAGENTS AND METHODS | BRENTANO BIOTECHNOLOGY ASSOCIATES (US) | 2025-07-31 | — | — | US | disclosed |
| EP-4034131-A1 | DIASTEREOMERIC LINKING REAGENTS FOR NUCLEOTIDE PROBES | Brentano Biotechnology Associates (US) | 2022-08-03 | — | — | EP | disclosed |
| US-20220073546-A1 | DIASTEREOMERIC LINKING REAGENTS FOR NUCLEOTIDE PROBES | BRENTANO BIOTECHNOLOGY ASSOCIATES (US) | 2022-03-10 | — | — | US | disclosed |
| WO-2021061154-A1 | DIASTEREOMERIC LINKING REAGENTS FOR NUCLEOTIDE PROBES | BRENTANO BIOTECHNOLOGY ASSOCIATES (US) | 2021-04-01 | — | — | WO | disclosed |
| US-20170210775-A1 | GUGGULPHOSPHOLIPID METHODS AND COMPOSITIONS | JINA PHARMACEUTICALS, INC. | 2017-07-27 | — | — | US | disclosed |
| US-9637515-B2 | Guggulphospholipid methods and compositions | JINA PHARMACEUTICALS, INC. (US) | 2017-05-02 | — | — | US | disclosed |
| EP-2088865-B1 | GUGGULPHOSPHOLIPID METHODS AND COMPOSITIONS | JINA PHARMACEUTICALS INC (US) | 2015-10-21 | — | — | EP | disclosed |
| EP-1795208-B1 | Glycerophosphoric acid ester derivative having polyfunctional metal chelate structure | FUJIFILM CORP (JP) | 2011-07-27 | — | — | EP | disclosed |
| US-5643948-A | ANTIINFLAMMATORY, ANTICANCER | PROCYON PHARMACEUTICALS, INC. (US) | 1997-07-01 | — | — | US | disclosed |
| US-5585481-A | VERSATILITY; NON-NUCLEOTIDE MONOMERIC UNIT HAVING A LIGAND AND FIRST AND SECOND COUPLING GROUPS WHICH ARE LINKED TO THE NON-NUCLEOTIDE MONOMERIC UNIT ; LABELS, INTERCALATORS, PROBES | GEN-PROBE INCORPORATED (US) | 1996-12-17 | — | — | US | disclosed |
| EP-0313219-B1 | Non-nucleotide linking reagents for nucleotide probes | GEN PROBE INC (US) | 1996-05-08 | — | — | EP | disclosed |
| US-5324631-A | Spectrum analysis of amplified hybrid products produced by contacting various fluorescent-labelled primers with the genomic DNA, particularly that of plants | PIONEER HI-BRED INTERNATIONAL, INC. | 1994-06-28 | — | — | US | disclosed |
| EP-0370317-B1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED 2-CHLOROPYRIDINES | BAYER AG (DE) | 1993-06-02 | — | — | EP | disclosed |
| US-5145842-A | Protein kinase c. modulators. d. | ALDER RESEARCH CENTER LIMITED PARTNERSHIP (US) | 1992-09-08 | — | — | US | disclosed |
| WO-1992002484-A1 | PROTEIN KINASE C MODULATORS WITH ANTI-INFLAMMATORY AND ANTIVIRAL ACTIVITY | ALDER RESEARCH CENTER LIMITED PARTNERSHIP (US) | 1992-02-20 | — | — | WO | disclosed |
| EP-0370317-A1 | Process for the preparation of substituted 2-chloropyridines | BAYER AG (DE) | 1990-05-30 | — | — | EP | disclosed |
| EP-0313219-A2 | Non-nucleotide linking reagents for nucleotide probes | GEN-PROBE INCORPORATED (US) | 1989-04-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100151002-A1 | Guggulphospholipid Methods and Compositions | SGMS2, SGMS1, PLA2G5 | CA12 3093/4885CA1 3241/4885CA2 4036/4885 |
| US-20170210775-A1 | GUGGULPHOSPHOLIPID METHODS AND COMPOSITIONS | SGMS1, SGMS2, GGPS1 | CA12 2532/4885CA1 2522/4885CA2 2837/4885 |
| US-20250243540-A1 | PROBE RELATED REAGENTS AND METHODS | DNTT, NCL, NT5C3B | CA12 1803/4885CA1 2366/4885CA2 2855/4885 |
| US-20220073546-A1 | DIASTEREOMERIC LINKING REAGENTS FOR NUCLEOTIDE PROBES | NCL, PCNA, DNTT | CA12 3596/4885CA1 3599/4885CA2 4067/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.